Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) EBIT Margin (2025 - 2026)

Updated

Global Innovative Platforms (GIPL) reported EBIT Margin of -476.55% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 334.40 percentage points from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) EBIT Margin (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Global Innovative Platforms' EBIT Margin came in at -361.67%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - -476.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -476.55%
Mar 31, 2026 -142.15%
Dec 31, 2025 -164.76%
API Access

Global Innovative Platforms EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=GIPL&period=max&api_key=YOUR_API_KEY